Series D - Timeline
Investment Firm
Overview
Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.
Announced Date
Jan 17, 2024
Funding Type
Series D
Highlights
Location
Switzerland, Europe
Social
Participant Investors
3
Round Details and Background
Timeline raised $64783848 on 2024-01-17 in Series D
Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 21, 2018 |  Series C - Timeline | - | 8.9M | |
| Apr 02, 2019 | Venture Round - Timeline | 1 | - | undefined |
| Aug 01, 2015 | Venture Round - Timeline | - | undefined | |
| Jan 17, 2024 | Series D - Timeline | 3 | - | 64.8M |
Recent Activity
News
Jan 22, 2024
pitchbook.com - Global VC deals for January 22, 2024
News
Jan 18, 2024
Silicon Canals - Swiss longevity biotech startup Timeline bags €60.6M from L’Oréal, Nestlé, others
News
Jan 18, 2024
Timeline Nutrition - Our latest financing round supported by L'Oréal and Nestlé
News
Jan 18, 2024
Business Wire India - Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé
News
Jan 17, 2024
Global Cosmetic Industry - L'Oreal Invests in Timeline to Boost the Skin's Healthspan & Longevity
News
Jan 17, 2024
Yahoo Finance - Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé